"Designing Growth Strategies is in our DNA"

U.S. Non-invasive Prenatal Testing (NIPT) Market Size, Share & Industry Analysis, By Product (Consumables & Reagents and Instruments), By Technology (Next Generation Sequencing (NGS), Microarray, Polymerase Chain Reaction (PCR), and Rolling Circular Amplification), By End-User (Hospitals and Clinical Laboratories), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108785

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of NIPT Tests Performed in the U.S., 2011-2023
    2. Adoption of NIPT Tests per 1000 Eligible Pregnant Women in the U.S., 2011 2023
    3. Technological Advancements in Non invasive Prenatal Testing (NIPT) Techniques
    4. Pricing Analysis, Key Brands / Key Players, 2023
    5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    6. Impact of COVID 19 on the Market
  5. U.S. Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Consumables & Reagents
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Technology
      1. Next Generation Sequencing (NGS)
      2. Microarray
      3. Polymerase Chain Reaction (PCR)
      4. Rolling Circular Amplification
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Illumina, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Natera, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Revvity Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Laboratory Corporation of America Holdings
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Eurofins Scientific
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Myriad, Inc 
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of NIPT Tests Performed in the U.S., 2011-2023
    2. Adoption of NIPT Tests per 1000 Eligible Pregnant Women in the U.S., 2011 2023
    3. Technological Advancements in Non invasive Prenatal Testing (NIPT) Techniques
    4. Pricing Analysis, Key Brands / Key Players, 2023
    5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    6. Impact of COVID 19 on the Market
  5. U.S. Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Consumables & Reagents
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Technology
      1. Next Generation Sequencing (NGS)
      2. Microarray
      3. Polymerase Chain Reaction (PCR)
      4. Rolling Circular Amplification
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Illumina, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Natera, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Revvity Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Laboratory Corporation of America Holdings
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Eurofins Scientific
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Myriad, Inc 
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01: U.S. Non-invasive Prenatal Testing (NIPT) Market Revenue Breakdown (USD billion, %) by Product, 2023-2032

Figure 02: U.S. Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Product, 2023 & 2032

Figure 03: U.S. Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Technology, 2023 & 2032

Figure 04: U.S. Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By End-user, 2023 & 2032

Figure 05: U.S. Non-invasive Prenatal Testing (NIPT) Market Share (%), By Company, 2023

Table 01: U.S. Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 02: U.S. Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Technology, 2019–2032

Table 03: U.S. Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By End-user, 2019–2032

U.S. Non-Invasive Prenatal Testing (NIPT) Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 77
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports